Consequences of ChemR23 Heteromerization with the Chemokine Receptors CXCR4 and CCR7

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  de Poorter, Cédric ^a   Baertsoen, Kevin ^a   Lannoy, Vincent ^b   Parmentier, Marc ^a   Springael, Jean Yves ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b Euroscreen SA   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CHEMR23; CHEMOKINE RECEPTOR CXCR4; PLERIXAFOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING COMPETITION; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; CELL MEMBRANE; CONTROLLED STUDY; DENDRITIC CELL; DIMERIZATION; HETEROMERIZATION; INTERNALIZATION; MOUSE; NONHUMAN;

ANIMALS; CELL MEMBRANE; CHO CELLS; CRICETINAE; CRICETULUS; GENE EXPRESSION REGULATION; HETEROCYCLIC COMPOUNDS; HUMANS; MICE; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, QUATERNARY; RECEPTORS, CCR7; RECEPTORS, CHEMOKINE; RECEPTORS, CXCR4; SUBSTRATE SPECIFICITY;

EID: 84874577195     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058075     Document Type: Article

References (35)

1. Gurevich VV, Gurevich EV, (2008) GPCR monomers and oligomers: it takes all kinds. Trends in Neurosciences 31: 74-81.
2. Terrillon S, Bouvier M, (2004) Roles of G-protein-coupled receptor dimerization - From ontogeny to signalling regulation. Embo Reports 5: 30-34.
3. Milligan G, (2004) G protein-coupled receptor dimerization: Function and ligand pharmacology. Mol Pharmacol 66: 1-7.
4. Springael JY, Urizar E, Parmentier M, (2005) Dimerization of chemokine receptors and its functional consequences. Cytokine Growth Factor Rev 16: 611-623.
5. Salanga CL, O'Hayre M, Handel T, (2009) Modulation of chemokine receptor activity through dimerization and crosstalk. Cell Mol Life Sci 66: 1370-1386.
6. Issafras H, Angers S, Bulenger S, Blanpain C, Parmentier M, et al. (2002) Constitutive agonist-independent CCR5 oligomerization and antibody-mediated clustering occurring at physiological levels of receptors. J Biol Chem 20 277: 34666-34673.
7. Sohy D, Yano H, De nadai P, Urizar E, Guillabert A, et al. (2009) Hetero-oligomerization of CCR2, CCR5, and CXCR4 and the protean effects of "selective" antagonists. J Biol Chem 284: 31270-31279.
8. El Asmar L, Springael JY, Ballet S, Andrieu EU, Vassart G, et al. (2005) Evidence for negative binding cooperativity within CCR5-CCR2b heterodimers. Mol Pharmacol 67: 460-469.
9. Sohy D, Parmentier M, Springael JY, (2007) Allosteric transinhibition by specific antagonists in CCR2/CXCR4 heterodimers. Journal of Biological Chemistry 282: 30062-30069.
10. Springael JY, Le Minh PN, Urizar E, Costagliola S, Vassart G, et al. (2006) Allosteric Modulation of Binding Properties between Units of Chemokine Receptor Homo- and Hetero-Oligomers. Mol Pharmacol 69: 1652-1661.
11. Benkirane M, Jin DY, Chun RF, Koup RA, Jeang KT, (1997) Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by ccr5delta32. J Biol Chem 272: 30603-30606.
12. Mellado M, Rodriguez-Frade JM, Vila-Coro AJ, de Ana AM, Martinez C, (1999) Chemokine control of HIV-1 infection. Nature 400: 723-724.
13. Mellado M, Rodriguez-Frade JM, Vila-Coro AJ, Fernandez S, Martin dA, et al. (2001) Chemokine receptor homo- or heterodimerization activates distinct signaling pathways. EMBO J 20: 2497-2507.
14. Sierro F, Biben C, Martinez-Munoz L, Mellado M, Ransohoff RM, et al. (2007) Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7. Proceedings of the National Academy of Sciences of the United States of America 104: 14759-14764.
15. Babcock GJ, Farzan M, Sodroski J, (2003) Ligand-independent dimerization of CXCR4, a principal HIV-1 coreceptor. Journal of Biological Chemistry 278: 3378-3385.
16. Toth PT, Ren DJ, Miller RJ, (2004) Regulation of CXCR4 receptor dimerization by the chemokine SDF-1 alpha and the HIV-1 coat protein gp120: A fluorescence resonance energy transfer (FRET) study. Journal of Pharmacology and Experimental Therapeutics 310: 8-17.
17. Contento RL, Molon B, Boularan C, Pozzan T, Manes S, et al. (2008) CXCR4-CCR5: a couple modulating T cell functions. Proc Natl Acad Sci U S A 105: 10101-10106.
18. Chakera A, Seeber RM, John AE, Eidne KA, Greaves DR, (2008) The Duffy antigen/receptor for chemokines exists in an oligomeric form in living cells and functionally antagonizes CCR5 signaling through hetero-oligomerization. Mol Pharmacol 73: 1362-1370.
19. Levoye A, Balabanian K, Baleux F, Bachelerie F, Lagane B, (2009) CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling. Blood 113: 6085-6093.
20. Wittamer V, Franssen JD, Vulcano M, Mirjolet JF, Le Poul E, et al. (2003) Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. Journal of Experimental Medicine 198: 977-985.
21. Parolini S, Santoro A, Marcenaro E, Luini W, Massardi L, et al. (2007) The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues. Blood 109: 3625-3632.
22. Zabel BA, Ohyama T, Zuniga L, Kim JY, Johnston B, et al. (2006) Chemokine-like receptor 1 expression by macrophages in vivo: Regulation by TGF-beta and TLR ligands. Experimental Hematology 34: 1106-1114.
23. Vermi W, Riboldi E, Wittamer V, Gentili F, Luini W, et al. (2005) Role of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skin. Journal of Experimental Medicine 201: 509-515.
24. Bozaoglu K, Bolton K, McMillan J, Zimmet P, Jowett J, et al. (2007) Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology 148: 4687-4694.
25. Roh SG, Song SH, Choi KC, Katoh K, Wittamer V, et al. (2007) Chemerin - A new adipokine that modulates adipogenesis via its own receptor. Biochemical and Biophysical Research Communications 362: 1013-1018.
26. Goralski KB, McCarthy TC, Hanniman EA, Zabel BA, Butcher EC, et al. (2007) Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. Journal of Biological Chemistry 282: 28175-28188.
27. Migeotte I, Communi D, Parmentier M, (2006) Formyl peptide receptors: a promiscuous subfamily of G protein-coupled receptors controlling immune responses. Cytokine Growth Factor Rev 17: 501-519.
28. Lutz MB, Kukutsch N, Ogilvie ALJ, Rossner S, Koch F, et al. (1999) An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. Journal of Immunological Methods 223: 77-92.
29. Guo RF, Ward PA, (2005) Role of C5A in inflammatory responses. Annual Review of Immunology 23: 821-852.
30. Bonecchi R, Galliera E, Borroni EM, Corsi MM, Locati M, et al. (2009) Chemokines and chemokine receptors: an overview. Front Biosci 14: 540-551.
31. Huttenrauch F, Pollok-Kopp B, Oppermann M, (2005) G protein-coupled receptor kinases promote phosphorylation and beta-arrestin-mediated internalization of CCR5 homo- and hetero-oligomers. J Biol Chem 280: 37503-37515.
32. Ali H, Richardson RM, Haribabu B, Snyderman R, (1999) Chemoattractant receptor cross-desensitization. J Biol Chem 274: 6027-6030.
33. Le Y, Wetzel MA, Shen W, Gong W, Rogers TJ, et al. (2001) Desensitization of chemokine receptor CCR5 in dendritic cells at the early stage of differentiation by activation of formyl peptide receptors. Clin Immunol 99: 365-372.
34. Finley MJ, Chen X, Bardi G, Davey P, Geller EB, et al. (2008) Bi-directional heterologous desensitization between the major HIV-1 co-receptor CXCR4 and the kappa-opioid receptor. J Neuroimmunol 197: 114-123.
35. Maurel D, Kniazeff J, Mathis G, Trinquet E, Pin JP, et al. (2004) Cell surface detection of membrane protein interaction with homogeneous time-resolved fluorescence resonance energy transfer technology. Anal Biochem. 329: 253-262.